Peroxisome Proliferator-Activated Receptor α in Lipid Metabolism and Atherosclerosis
- 1 January 2015
- book chapter
- Published by Elsevier
- Vol. 71, 171-203
Abstract
No abstract availableKeywords
This publication has 143 references indexed in Scilit:
- Effects of Three Different Fibrates on Intrahepatic Cholestasis Experimentally Induced in RatsPPAR Research, 2013
- MicroRNA-21 targets peroxisome proliferators-activated receptor-α in an autoregulatory loop to modulate flow-induced endothelial inflammationProceedings of the National Academy of Sciences, 2011
- Peroxisome Proliferator-Activated Receptor Alpha Target GenesPPAR Research, 2010
- Fenofibrate differentially regulates plasminogen activator inhibitor-1 gene expression via adenosine monophosphate–activated protein kinase–dependent induction of orphan nuclear receptor small heterodimer partner #Hepatology, 2009
- PPARs and the Cardiovascular SystemAntioxidants & Redox Signaling, 2009
- The dual PPARα/γ agonist tesaglitazar blocks progression of pre‐existing atherosclerosis in APOE*3Leiden.CETP transgenic miceBritish Journal of Pharmacology, 2009
- Potent and Selective PPAR-α Agonist LY518674 Upregulates Both ApoA-I Production and Catabolism in Human Subjects With the Metabolic SyndromeArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Critical Role of PPAR-α in Perfluorooctanoic Acid– and Perfluorodecanoic Acid–Induced Downregulation of Oatp Uptake Transporters in Mouse LiversToxicological Sciences, 2008
- Inhibition of vascular inflammation by dehydroepiandrosterone sulfate in human aortic endothelial cells: Roles of PPARα and NF-κBVascular Pharmacology, 2008
- Pseudomonas aeruginosaand sPLA2 IB stimulate ABCA1-mediated phospholipid efflux via ERK-activation of PPARα–RXRBiochemical Journal, 2007